A PBMC-Humanized Mouse Model for Quantitating Cytokine Release Syndrome Caused by Immunotherapy

May 21, 2020

Danying Cai, Ph.D., presents "A Rapid, Sensitive, and Reproducible PBMC-Humanized Mouse Model for Quantitating Cytokine Release Syndrome Caused by Immunotherapy"

A PBMC-Humanized Mouse Model for Quantitating Cytokine Release Syndrome Caused by Immunotherapy

PBMC-Humanized NSG-(KbDb)null (IA)null Mouse Model for Evaluation of Immuno-Oncology Drug Efficacy

Humanized NSG-Tg(Hu-IL15) Mouse Model for Evaluation of NK cells Based Drug Efficacy

Humanized Mouse Model for Evaluation of Bispecific Antibody Efficacy & Drug-Induced Cytokine Release

Evaluating PDX Breast Cancer Models Implanted Subcutaneously vs. Mammary Fat Pad

Aging Effect on Toxicity, Efficacy, & Immunomodulation via Chemotherapy in C57BL/6J Syngeneic Model

Preclinical Mouse Model to Evaluate Efficacy and Potential CRS of CAR T Cell Therapy

Preclinical Evaluation of Potential CRS & Efficacy of Bispecific Antibodies in PBMC-Humanized Mice

Dose-Response & Time Course of TGN1412 Induced Human Cytokines in Humanized PBMC Mouse Model for CRS